Original ContributionLack of CD 29 (β1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis*
References (45)
- et al.
Malignant angioendotheliomatosis—A true lymphoma: A case of intravascular malignant lymphomatosis studied by Southern blot hybridization analysis
Hum Pathol
(1988) - et al.
Cell membrane-associated mucins and their adhesion-modulating property
Trends Biochem Sci
(1992) - et al.
CD44: A molecule involved in leukocyte adherence and T-cell activation
Immunol Today
(1989) Integrins: A family of cell surface receptors
Cell
(1987)Integrins: Versatility, modulation, and signaling in cell adhesion
Cell
(1992)- et al.
Report of the Symposium on Cutaneous Lymphomas: Sixth international conference on malignant lymphoma
Ann Oncol
(1997) - et al.
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
Cell
(1990) - et al.
Intravascular malignant lymphomatosis: A case of T-cell lymphoma probably associated with human T-cell lymphotropic virus
Hum Pathol
(1991) - et al.
Angiotropic large cell lymphoma (intravascular lymphomatosis) occurring after follicular small cleaved lymphoma
- et al.
Intravascular lymphomatosis: Clinicopathologic features and differential diagnosis
Semin Diagn Pathol
(1991)
Zur Kenntnis der systemisierten Endotheliomatose der cutanen Blutgefasse
Hautarzt
(1959)
Malignant lymphoma and malignant angioendotheliomatosis: One disease
Cancer
(1985)
Further evidence that “malignant angioendotheliomatosis” is an angiotropic large-cell lymphoma
N Engl J Med
(1986)
Intravascular (Angiotropic) large cell lymphoma: Determination of monoclonality by polymerase chain reaction on paraffin-embedded tissues
Mod Pathol
(1994)
Intravascular large cell lymphoma coexisting within hemangiomas of the skin
Am J Surg Pathol
(1997)
Intravascular lymphomatosis (malignant angioendotheliomatosis): A B-cell neoplasm expressing surface homing receptors
Mod Pathol
(1988)
Case 39, 1986
N Engl J Med
(1986)
Case 31, 1995
N Engl J Med
(1995)
Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis
Int J Cancer
(1989)
A case of intravascular malignant lymphomatosis (angiotropic large cell lymphoma) presenting memory T cell phenotype and its expression of adhesion molecules
J Dermatol
(1992)
Suppression of cellular aggregation by high levels of episialin
Cancer Res
(1992)
Polysialylated N-CAM, chromogranin A and B, and secretogranin II in neuroendocrine tumors of the lung
Virchows Arch
(1997)
Cited by (278)
Cancer-associated spinal cord infarction: A systematic review and analysis of survival predictors
2023, Journal of the Neurological SciencesCharacteristics of Renal Intravascular Large B-cell Lymphoma
2023, Kidney International ReportsFrom the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells
2022, Annals of Diagnostic PathologyCutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022, Presse MedicaleICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review
2021, AACE Clinical Case ReportsCitation Excerpt :Treatment with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone) combined with an intrathecal infusion of methotrexate (MTX) is recommended for IVLBCL with central nervous system involvement. Although the reasons for intravascular localization of IVLBCL are unknown, it has been reported that the absence of intercellular adhesion molecule 1 (ICAM1) and β1 integrin (CD29) surface ligands may disable lymphoma cells from diapedesis across the endothelium.2,3 IVLBCL with pituitary involvement is rare.
- *
Presented in part at the XXII Congress of the International Academy of Pathology and 13th World Congress of Academic and Environmental Pathology, Nice (France), October 18–23, 1998.
Copyright © 2000 Published by Elsevier Inc.